Status:
TERMINATED
Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Collaborating Sponsors:
Centocor, Inc.
Conditions:
Crohn Disease
Eligibility:
All Genders
18+ years
Brief Summary
A multi-centre retrospective review of fistulizing Crohn's disease (CD) patient charts will capture data to measure health care resource utilization associated with the use of Infliximab for treatment...
Detailed Description
This study population was chosen from a non-probability sample.
Eligibility Criteria
Inclusion
- Treatment with infliximab for fistulizing CD.
- Administration of at least one infliximab infusion \>=12 months before the chart review.
- 18 years of age or over (men and women).
Exclusion
- Subjects not followed for a full year after their first infusion of infliximab.
- Subjects not followed for a full year prior to their first infusion of infliximab.
- Subjects who had participated in clinical studies during the data collection timeframe.
Key Trial Info
Start Date :
April 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00705471
Start Date
April 1 2005
End Date
September 1 2007
Last Update
April 8 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.